Medicalgorithmics S.A. is a Poland-based medical technology company specializing in AI-powered and noninvasive solutions for cardiac diagnostics. It develops and provides FDA-certified algorithms, software, and devices that enable precise detection, classification, and analysis of cardiac arrhythmias through advanced ECG monitoring. The company's flagship products include the PocketECG system for wearable monitoring, the DeepRhythm Platform for cloud-based AI analysis, DRAI algorithms for superior diagnostic accuracy, and innovative VCAST technology for virtual cardiac stress testing. These solutions support healthcare providers, physicians, and medical technology firms in delivering more effective diagnosis and personalized treatment globally. Medicalgorithmics S.A. operates through subsidiaries like Medicalgorithmics India for distribution and ECG services in the Asia-Pacific region, serving partners in over 25 countries including the United States, Canada, Australia, and Europe. Founded in 2005 and headquartered in Warsaw, Poland, it focuses on high-margin software sales, R&D in predictive analytics, and integrations with hardware-agnostic systems to enhance cardiology outcomes.
Markedsdata leveret af TwelveData og Morningstar
Baseret på 2 analytikere